[Tree] C3.ai stock performance and software earnings reports
Version 0.17 (2024-12-05 16:50:20.879000)
updates: C3.ai stock rises after positive earnings reports
- ➔
Version 0.16 (2024-07-14 10:20:13.505000)
updates: Daiwa Securities Group decreases stock holdings
- ➔
Version 0.14 (2024-07-12 18:07:28.408000)
updates: Highlights C3.ai's strong cash reserves and potential for growth
- ➔
- ➔
- ➔
- ➔
- ➔
- ➔
- ➔
Version 0.13 (2024-07-06 10:45:59.900000)
updates: C3.ai stock faces potential undervaluation amidst growth cycle
- ➔
- ➔
- ➔
- ➔
- ➔
- ➔
Version 0.12 (2024-07-02 19:10:14.351000)
updates: Being AI reports net loss in full year 2024 earnings
- ➔
- ➔
- ➔
- ➔
- ➔
Version 0.11 (2024-07-02 18:52:02.245000)
updates: Integration of Being AI's full year 2024 earnings report
- ➔
- ➔
- ➔
- ➔
Version 0.1 (2024-06-28 13:15:45.622000)
updates: Integration of analysis on C3.ai's revenue growth and mounting losses
- ➔
- ➔
- ➔
- ➔
- ➔
Version 0.09 (2024-06-28 13:04:39.286000)
updates: C3.ai's impressive revenue growth and mounting losses
- ➔
- ➔
- ➔
- ➔
Version 0.08 (2024-04-02 20:46:56.204000)
updates: Includes information about the decline in C3.ai (NYSE:AI) shares
- ➔
- ➔
- ➔
Version 0.07 (2024-03-26 07:10:12.640000)
updates: Shares of IQ-AI Limited (LON:IQAI) drop in trading
- ➔
- ➔
Version 0.06 (2024-03-14 09:19:07.280000)
updates: Shares of Datametrex AI Limited (CVE:DM) dropped 11.1%
- ➔
Version 0.05 (2024-03-02 19:23:19.670000)
updates: Coverage and ratings for MoonLake Immunotherapeutics
- ➔
- ➔
- ➔
Version 0.04 (2024-03-02 08:25:06.536000)
updates: Analysts issue coverage and ratings for 4D Molecular Therapeutics and Desktop Metal
- ➔
- ➔
Version 0.02 (2023-10-20 13:23:30.030000)
updates: Expanded and reorganized information, added details and context
- ➔
Version 0.01 (2023-10-08 16:07:20.699000)
updates: Combined information about the global HIV Diagnosis Market and the Rare Disease Treatment Market for 2031
- ➔
- ➔